These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 23253961)
1. Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis. Pinto R; Lopes T; Silva J; Silva C; Dinis P; Cruz F J Urol; 2013 Feb; 189(2):548-53. PubMed ID: 23253961 [TBL] [Abstract][Full Text] [Related]
2. Ulcerative and nonulcerative forms of bladder pain syndrome/interstitial cystitis do not differ in symptom intensity or response to onabotulinum toxin A. Pinto R; Lopes T; Costa D; Barros S; Silva J; Silva C; Cruz C; Dinis P; Cruz F Urology; 2014 May; 83(5):1030-4. PubMed ID: 24767520 [TBL] [Abstract][Full Text] [Related]
3. Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial. Pinto RA; Costa D; Morgado A; Pereira P; Charrua A; Silva J; Cruz F J Urol; 2018 Apr; 199(4):998-1003. PubMed ID: 29031769 [TBL] [Abstract][Full Text] [Related]
4. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome. Kuo HC Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103 [TBL] [Abstract][Full Text] [Related]
5. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis. Lee CL; Kuo HC Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677 [TBL] [Abstract][Full Text] [Related]
6. Repeated onabotulinumtoxin-a injections provide better results than single injection in treatment of painful bladder syndrome. Kuo HC Pain Physician; 2013 Jan; 16(1):E15-23. PubMed ID: 23340540 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome. Shie JH; Liu HT; Wang YS; Kuo HC BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596 [TBL] [Abstract][Full Text] [Related]
8. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome. Chuang YC; Kuo HC J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358 [TBL] [Abstract][Full Text] [Related]
9. Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome. Chung SD; Kuo YC; Kuo HC Pain Physician; 2012; 15(3):197-202. PubMed ID: 22622903 [TBL] [Abstract][Full Text] [Related]
10. Preliminary results of suburothelial injection of botulinum a toxin in the treatment of chronic interstitial cystitis. Kuo HC Urol Int; 2005; 75(2):170-4. PubMed ID: 16123573 [TBL] [Abstract][Full Text] [Related]
11. Intravesical injection of botulinum toxin A for treatment of interstitial cystitis/bladder pain syndrome: 10 years of experience at a single center in China. Gao Y; Liao L Int Urogynecol J; 2015 Jul; 26(7):1021-6. PubMed ID: 25690160 [TBL] [Abstract][Full Text] [Related]
12. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup. Giannantoni A; Porena M; Costantini E; Zucchi A; Mearini L; Mearini E J Urol; 2008 Mar; 179(3):1031-4. PubMed ID: 18206941 [TBL] [Abstract][Full Text] [Related]
13. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens. Lai MC; Kuo YC; Kuo HC Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment. Jhang JF; Yu WR; Kuo HC Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828435 [TBL] [Abstract][Full Text] [Related]
15. Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxina injection in the treatment of interstitial cystitis refractory to conventional treatment-A prospective, randomized, clinical trial. Jiang YH; Jhang JF; Lee CL; Kuo HC Neurourol Urodyn; 2018 Apr; 37(4):1467-1473. PubMed ID: 29331031 [TBL] [Abstract][Full Text] [Related]
16. Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome. Lee CL; Kuo HC Toxins (Basel); 2015 Oct; 7(10):4283-93. PubMed ID: 26506388 [TBL] [Abstract][Full Text] [Related]
17. Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis. Nickel JC; Tripp D; Teal V; Propert KJ; Burks D; Foster HE; Hanno P; Mayer R; Payne CK; Peters KM; Kusek JW; Nyberg LM; J Urol; 2007 May; 177(5):1832-6. PubMed ID: 17437831 [TBL] [Abstract][Full Text] [Related]
18. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. Kuo HC; Chancellor MB BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543 [TBL] [Abstract][Full Text] [Related]
19. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859 [TBL] [Abstract][Full Text] [Related]
20. Safety and dose flexibility clinical evaluation of intravesical liposome in patients with interstitial cystitis or painful bladder syndrome. Lee WC; Chuang YC; Lee WC; Chiang PH Kaohsiung J Med Sci; 2011 Oct; 27(10):437-40. PubMed ID: 21943815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]